Koichiro Asano Selected Research

Antibodies

1/2022	Prevalence of inhaled allergen-specific IgE antibody positivity in the healthy Japanese population.
1/2021	Optimal Aspergillus fumigatus and Asp f 1 serum IgG cut-offs for the diagnosis of allergic bronchopulmonary aspergillosis.
9/2018	Concordance between Aspergillus-specific precipitating antibody and IgG in allergic bronchopulmonary aspergillosis.
7/2018	Allergic bronchopulmonary mycosis - pathophysiology, histology, diagnosis, and treatment.
1/2018	Allergic bronchopulmonary aspergillosis in Japan: A nationwide survey.
1/2015	Lung cancer associated with seronegative myasthenia gravis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichiro Asano Research Topics

Disease

44	Asthma (Bronchial Asthma) 04/2024 - 10/2002
25	Inflammation (Inflammations) 04/2024 - 02/2002
13	Neoplasms (Cancer) 12/2022 - 09/2009
11	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2015
9	Lung Neoplasms (Lung Cancer) 09/2023 - 09/2009
8	Allergic Bronchopulmonary Aspergillosis 04/2024 - 01/2018
8	Pneumonia (Pneumonitis) 01/2024 - 01/2010
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 11/2003
7	COVID-19 01/2024 - 09/2021
6	Eosinophilia 02/2024 - 03/2005
6	Infections 12/2022 - 04/2014
6	Emphysema 01/2022 - 08/2012
4	Rhinosinusitis 04/2024 - 04/2015
4	Fibrosis (Cirrhosis) 01/2024 - 11/2012
4	Pleural Effusion (Pleural Effusions) 02/2021 - 09/2015
3	Dyspnea (Shortness of Breath) 12/2023 - 08/2012
3	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 10/2020
3	Allergic Rhinitis 12/2022 - 03/2005
3	Pulmonary Hypertension 04/2022 - 10/2013
3	Pulmonary Arterial Hypertension 01/2021 - 10/2013
3	Eczema 12/2020 - 03/2011
3	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2020 - 05/2012
3	Adenocarcinoma of Lung 09/2020 - 09/2009
3	Lung Injury 01/2018 - 03/2008
3	Acute Lung Injury 03/2010 - 03/2008
2	Pulmonary Edema 01/2023 - 03/2010
2	Lung Diseases (Lung Disease) 01/2023 - 01/2019
2	Febrile Neutropenia 12/2022 - 04/2022
2	Disease Progression 09/2022 - 03/2012
2	Cough 05/2022 - 09/2014
2	Organizing Pneumonia 05/2022 - 04/2022
2	Hypoxia (Hypoxemia) 04/2022 - 06/2009
2	Empyema 06/2021 - 01/2017
2	Idiopathic Pulmonary Fibrosis 02/2021 - 03/2010
2	Hypersensitivity (Allergy) 01/2021 - 01/2021
2	Anaphylaxis (Anaphylactic Shock) 01/2021 - 01/2021
2	Obstructive Sleep Apnea 01/2017 - 07/2016
2	Osteoporosis 02/2015 - 08/2012
2	Respiratory Hypersensitivity 05/2014 - 12/2004
2	Sepsis (Septicemia) 04/2014 - 06/2012
2	Carcinoma (Carcinomatosis) 03/2012 - 03/2010
1	Allergic Fungal Sinusitis 04/2024
1	Keratoconjunctivitis 04/2024
1	Otitis Media 04/2024
1	Bronchitis 04/2024
1	Thrombosis (Thrombus) 01/2024

Drug/Important Bio-Agent (IBA)

16	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2023 - 10/2002
9	Immunoglobulin E (IgE)IBA 02/2024 - 01/2018
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2012
7	AllergensIBA 11/2023 - 01/2008
7	ProstaglandinsIBA 01/2011 - 02/2002
6	Immunoglobulin G (IgG)IBA 02/2024 - 05/2014
6	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 04/2014
6	AntibodiesIBA 01/2022 - 01/2015
6	CytokinesIBA 12/2020 - 11/2012
5	Oxygen (Dioxygen)IBA 01/2023 - 08/2012
5	Prostaglandins DIBA 11/2012 - 03/2005
4	Interleukin-33IBA 12/2023 - 01/2013
4	InterleukinsIBA 01/2023 - 05/2014
3	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 05/2014
3	ErbB Receptors (EGF Receptor)IBA 05/2022 - 07/2011
3	COVID-19 VaccinesIBA 05/2022 - 01/2021
3	Carboplatin (JM8)FDA LinkGeneric 04/2022 - 11/2003
3	PeriostinIBA 01/2021 - 04/2015
3	AntigensIBA 01/2018 - 07/2013
3	Interleukin-13IBA 03/2016 - 11/2012
3	Methacholine Chloride (Methacholine)FDA Link 05/2014 - 01/2008
3	AcidsIBA 01/2010 - 03/2005
2	Phenobarbital (Luminal)FDA Link 04/2024 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2019
2	CollagenIBA 12/2023 - 01/2019
2	Bleomycin (Blenoxane)FDA LinkGeneric 12/2023 - 01/2019
2	GlucocorticoidsIBA 01/2023 - 06/2009
2	Monoclonal AntibodiesIBA 01/2023 - 10/2020
2	pembrolizumabIBA 11/2022 - 04/2022
2	Tyrosine Kinase InhibitorsIBA 05/2022 - 09/2020
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2022 - 09/2009
2	Immune Checkpoint InhibitorsIBA 04/2022 - 11/2019
2	16S Ribosomal RNAIBA 06/2021 - 01/2017
2	Prednisolone (Predate)FDA LinkGeneric 02/2021 - 01/2015
2	mepolizumabIBA 10/2020 - 09/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020 - 04/2015
2	Omalizumab (Xolair)FDA Link 10/2020 - 01/2020
2	prostaglandin D2 receptorIBA 01/2019 - 01/2011
2	Volatile Organic CompoundsIBA 01/2017 - 01/2017
2	Interleukin-5 (Interleukin 5)IBA 03/2016 - 03/2005
2	Interleukin-23 (Interleukin 23)IBA 09/2015 - 05/2014
2	LipocalinsIBA 11/2012 - 06/2009
2	Docetaxel (Taxotere)FDA Link 09/2009 - 11/2003
2	pranlukastIBA 08/2009 - 10/2002
2	Prostaglandin D2IBA 06/2009 - 01/2008
2	Thromboxane Receptors (Thromboxane Receptor)IBA 12/2008 - 03/2005
2	Prostaglandin H2 Thromboxane A2 ReceptorsIBA 01/2008 - 12/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2008 - 02/2002
1	PlasticsIBA 04/2024

Therapy/Procedure

15	Therapeutics 06/2023 - 08/2006
5	Drug Therapy (Chemotherapy) 12/2022 - 09/2009
3	Aftercare (After-Treatment) 08/2022 - 05/2012
2	Chemoradiotherapy 09/2020 - 01/2015
2	Combination Drug Therapy (Combination Chemotherapy) 09/2009 - 11/2003